The Karl G. Blume, MD Memorial Lectureship was established to honor Dr. Blume’s countless contributions to the field of blood and marrow transplantation, and to Stanford University and Stanford Hospital and Clinics. The lectureship is held the second Wednesday of each April at Stanford University’s Department of Medicine Grand Rounds.
Dr. Blume and his team conducted Stanford’s first successful Bone Marrow Transplant on November 2, 1987. Today the program provides transplants to over 300 adult patients a year, with over 5,000 patients receiving transplants during the past 26 years.
The 2015 Speaker is: Stephen J Forman, MD, FACP
Chair, Department of Hematology and Hematopoietic Cell Transplantation
City of Hope
Stephen J. Forman joined City of Hope’s Hematology and Bone Marrow Transplantation program in 1978, subsequently becoming the chair in 1987, and he is a professor of hematology/oncology. Dr. Forman is the program leader for COH’s NCI-designated Comprehensive Cancer Center’s Hematologic Malignancies Program and is the director of the T Cell immunotherapy treatments for both hematologic malignancy and solid tumors. For many years he has been listed among the best cancer doctors in the U.S.
An international leader in the field of hematologic malignancy and bone marrow transplantation, Dr. Forman is co-editor of Thomas’ Hematopoietic Cell Transplantation, a definitive textbook for scientists and health care professionals.
Prior to joining City of Hope in 1978, Dr. Forman earned his bachelor’s degree, cum laude, in philosophy from St. John’s College in Annapolis, Maryland and his medical degree with honors from the University of Southern California. He interned and served his residency in internal medicine at Harbor General-University of California Los Angeles Hospital, after which he completed fellowships in hematology at Los Angeles County University of Southern California Medical Center and in medical oncology at City of Hope.
More information about the event can be found here.
Presenter: Mark Davis, PhD
Professor, Microbiology and Immunology
Stanford University
Mark Davis obtained a BA in molecular biology from Johns Hopkins University in Baltimore, MD in 1974 and Ph.D. from California Institute of Technology in Pasadena, Ca in 1981. He worked on immunology research for more than 25 years, first as a post-doctoral researcher at the Immunology Laboratory of the National Institutes of Health in Bethesda, MD, then at Cold Spring Harbor Laboratory in New York before joining the Department of Microbiology and Immunology at the Stanford University School of Medicine, where he became a professor at the Howard Hughes Medical Institute in 1991. He also served for several years in the Advisory Committee of the Damon Runyon-Walter Winchell Cancer Research Foundation.
Professor Davis’s research centers on the molecular basis of T cell and B cell recognition. In particular, he studied the biochemical basis of T cell receptor binding to antigen/MHC complexes. He and Professor Mak independently cloned the first gene for T-cell receptors, allowing these immune cells to recognize and inactivate foreign proteins and viruses. This groundbreaking work revolutionized the field of immunology. Davis and his group also described the augmentation of responses triggered in T cells as a result of antigen presentation by B cells, dendritic cells or macrophages.
Author of more than 200 papers, Professor Davis received numerous awards and distinctions. In addition to the King Faisal International Prize for Medicine, his awards include: the Milton and Francis Clauser Doctoral Prize from Caltech; Passano Young Scientist Award; Eli Lilly Award in Microbiology and Immunology; the Howard Taylor Ricketts Award; Gairdner Prize; General Motors Cancer Prize – Sloan Award; Novartis Prize for Basic Immunology; William B. Coley Award; Pius XI Award; Rose Payne Award; Ernst W. Bertner Award; Paul Ehrlich Prize and Distinguished Alumni Award (Caltech). He is a Member of the National Academy of Sciences and the National Institute of Medicine and was the Newton-Abraham Visiting Professor at the University of Oxford.
Professor Davis chaired the Department of Microbiology and Immunology at Stanford from 2002-2004. In 2004, he became Director of the Stanford Institute for Immunity, Transplantation and Infection and between 2002-2004, he was the Burt and Marion Avery Family Professor of Immunology and is now Professor of Immunology and Microbiology at the Stanford University School of Medicine.
Presenter: Jane Tan, MD, PhD
Professor of Medicine (Nephrology)
Stanford University
Jane Tan, MD, PhD, is an assistant professor of nephrology at Stanford University. Her research explores the function older kidneys that have been transplanted into patients compared with younger ones. She received her MD and her PhD from the University of Rochester.
Read more about her work here.
Presenter: Andrew Pipe, MD
Chief, Division of Prevention and Rehabilitation
University of Ottawa Heart Institute
Dr. Andrew Pipe is Chief of the Division of Prevention and Rehabilitation at the University of Ottawa Heart Institute and Professor in the Faculty of Medicine at the University of Ottawa. He received his MD from Queen’s University in Kingston, Ontario, in 1974.
Dr. Pipe is Canada’s foremost expert on smoking cessation. He was instrumental in the development of the widely adopted Ottawa Model for Smoking Cessation at the Heart Institute.
Recognized as one of Canada’s leading experts in cardiovascular disease prevention, physical activity and health, and smoking cessation, Dr. Pipe has addressed audiences in over 30 nations and is frequently consulted on issues related to tobacco use and smoking cessation, drug use in sport, and physical activity and health. A former Chair of Physicians for a Smoke-Free Canada, Dr. Pipe is the recipient of the Canadian Cardiovascular Society Dr. Harold N. Segall Award of Merit.
In addition to his clinical responsibilities, Dr. Pipe has been extensively involved in sports and sport medicine for many years. He is currently President of the Commonwealth Games Association of Canada. He served as a physician at ten Olympic Games and has been Team Physician for Canada’s National Men’s Basketball Team since 1978. He served as Chair of the Canadian Centre for Ethics in Sport from its inception until 2003.
Dr. Pipe is the recipient of the International Olympic Committee’s Award for Sport, Health and Well-being, and is a member of the Canadian Olympic Hall of Fame. He has received honourary degrees from Queen’s University (LLD); Brock University (DSc) in St. Catharines, Ontario; and the University of Guelph (DSc) in Guelph, Ontario. He was formerly Vice Chair of the Board of Trustees at Queen’s University. In 2002 Dr. Pipe was named to the Order of Canada.
Presenter: Nelson Jen An Chao, MD, MBA
Chief, Division of Cell Therapy
Duke University
Nelson J. Chao, MD, MBA, is the Donald D. and Elizabeth G. Cooke Professor in Cancer Research and Professor of Medicine and Immunology and the Chief of the Division of Hematological Malignancies and the Division of Cellular Therapy/BMT at Duke University. He received his undergraduate degree from Harvard University, MD from Yale University and his post-graduate training at Stanford University. He was the Associate Director of Stem Cell Transplantation at Stanford University prior to moving to Duke University in 1996 as the Director of the Bone Marrow Transplantation Program. The program was renamed as the Division of Cellular Therapy/BMT. He is also the Co-Director of the Clinical Stem Cell Transplantation Laboratory and continues to direct his own research laboratory focused on understanding and preventing graft-versus-host disease and improving immune reconstitution. He is also the Director of Global Cancer for the Duke Cancer Institute and the Duke Global Health Institute. In 2012, he has also become the Chief of the Division of Hematological Malignancies.
Dr. Chao obtained his MBA from the Fuqua School of Business at Duke University in 2000. He is the author of over 200 peer-reviewed papers, 25 book chapters and one book. He is also a co-founder of two start up biotechnology companies in Research Triangle Park, Aldagen and C2 Regenerate. Nationally, he is the co-chair of the Radiation Injury Treatment Network (RITN) and the Principal Investigator for a Program Project Grant in stem cell transplantation and the Center for Medical Countermeasures against Radiation.
Presenter: Robert Shafer, MD.
Click HERE to register!
The mission of the Stanford Center for Clinical Research (SCCR) includes offering educational resources, training, and support for investigators and research staff. We have invited Clinical Assistant Professor of Orthopedic Surgery, Emily Kraus, MD, to present on the basics of Sports Medicine and sports related injuries. Injuries in sports are common and can lead to the premature end of a season or even an athletic career. This talk will review the role of the sports medicine physician in the athlete’s care providing, followed by a discussion of the epidemiology, risk factors, types of sports injuries, and management approach.
At the conclusion of this class, you will be able to:
- Understand the role of the sports medicine physician in the care of the athlete
- Define acute and chronic sports injury
- Define a concussion (mild traumatic brain injury)
- Understand the epidemiology and risk factors of sports injuries
- Explore new research and concepts related to sports injuries
- Understand the most common types of sports injuries and approach to management
Attendance is open to all research staff
About the Instructor:
Emily Kraus, MD, is a Clinical Assistant Professor at Stanford Children’s Orthopedic and Sports Medicine Center. She specializes in Physical Medicine and Rehabilitation (PM&R) sports medicine and takes a unique approach to the diagnosis, treatment, and prevention of sports injuries in athletes of all ages. She is involved in multiple Stanford IRB-approved research projects, including The Healthy Runner Project, a multicenter prospective interventional study focused on bone stress injury prevention in collegiate middle and long distance runners. Dr. Kraus also spends time performing gait analysis at the Stanford Run Safe Injury Prevention Program and serves as a medical advisors for the Adaptive Sports Injury Prevention Program at the Palo Alto VA. She has research and clinical interests in endurance sports medicine, injury prevention, running biomechanics, the prevention of bone stress injuries in collegiate athletes and the promotion of health and wellness at any age of life. She has completed seven marathons including Boston Marathon twice and one 50k ultramarathon. With running and staying physically active as one of her personal passions, she recognizes the importance of fitness for overall wellbeing and the prevention of chronic medical conditions.
Presenter: Dr. D. Kathryn Tierney, RN, PhD
Click HERE to Register!
The mission of the Stanford Center for Clinical Research (SCCR) includes offering educational resources, training, and support for investigators and research staff. We have invited Clinical Assistant Professor and Oncology Clinical Nurse Specialist, Dr. D. Kathryn Tierney, RN, PhD, to present on the important topic of Blood and Marrow Transplantation (BMT).
At the conclusion of this class, you will be able to:
- Understand the basics of Blood and Marrow Transplantation
- Describe hematopoiesis and possible complications
- Define different types of transplantation and types of grafts
- Identify autologous and allogeneic transplantation
- Outline who is a candidate for BMT, how to determine eligibility, and how to choose the type of transplant for an individual
- State the steps of a transplant, the preparative regimen, and infusing the graft
- Recognize the recovery process and outcomes of transplantation
Attendance is open to all research staff
About the Instructor:
Kathryn Tierney, RN, PhD, is a Clinical Assistant professor of Medicine in the division of Primary Care and Population Health at Stanford School of Medicine, and an Oncology Clinical Nurse Specialist in the division of Blood and Marrow Transplantation program at Stanford Health Care. Dr. Tierney has been caring for blood and marrow transplant recipients and their families for over 30 years. Her scholarly activities include teaching, mentoring and research. Her current research focuses on survivorship including quality of life, social adaptation and altered sexual health. Dr. Tierney is actively involved in professional organizations and has held leadership positions within the Oncology Nursing Society and American Society of Blood and Marrow Transplantation. She is the Co-Chair of Patient Centered HSCT Outcome Research, and Patient Education Advisory Group, in the National Marrow Donor Program. She is the recipient of multiple awards including the Lifetime Achievement Award of American Society of Blood and Marrow Transplantation in 2017.
BRN OPTIONAL
Spectrum is an approved provider by the California Board of Registered Nursing, Provider Number CEP15435 for 2 contact hour(s).
To receive your certificate with BRN credit, you are required to complete an evaluation at the conclusion of this class.
BRN Cancellation Policy: If you wish to cancel your registration, please contact the course coordinators, Susan Saba, ssaba@stanford.edu or Kiera Davis, klarsen5@stanford.edu.